Tumor acidity as evolutionary spite

Cancers

Volumn 3, Issue 1, 2011, Pages 408-414

  Alfarouk, Khalid O ^a,b   Muddathir, Abdel Khalig ^b   Shayoub, Mohammed E A ^b  

^a Africa City of Technology   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Cannibalsim; MAICS; Spite; Warburg effect

Indexed keywords

GLUCOSE;

ACIDITY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL INTERACTION; CELL METABOLISM; CELL TYPE; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; GLUCOSE METABOLISM; HUMAN; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR ACIDITY; TUMOR MICROENVIRONMENT;

EID: 79953721474     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010408     Document Type: Article

References (33)

1. Racker, E. History of the Pasteur effect and its pathobiology. Mol. Cell Biochem. 1974, 5, 17-23.
2. Gatenby, R.A.; Gillies, R.J. Why cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4, 891-899.
3. Robey, I.F.; Baggett, B.K.; Kirkpatrick, N.D.; Roe D.J.; Dosescu, J.; Sloane, B.F.; Hashim, A.I.; Morse, D.L.; Raghunand, N; Gatenby, R.A.; Gillies, R.J. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009, 69, 2260-2268.
4. Foster, K.R.; Wenseleers T.; Ratnieks, F.L.W. Spite: Hamilton's unproven theory. Ann. Zool. Fennici. 2001, 38, 229-238.
5. Said, H.M.; Supuran, C.T.; Hageman, C.; Staab A.; Polat, B.; Katzer A.; Scozzafava, A.; Anacker, J.; Flentje, M.; Vordermark, D. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Curr. Pharm. Des. 2010, 16, 3288-3299.
6. Supuran, C.T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
7. Fais, S.; De Milito A.; You H.; Qin, W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res. 2007, 67, 10627-10630.
8. Silva, A.S.; Yunes, J.A.; Gillies, R.J.; Gatenby, R.A. The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res. 2009, 15, 2677-2684.
9. Gatenby, R.A.; Gawlinski, E.T.; Gmitro, A.F.; Kaylor, B.; Gillies, R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006, 66, 5216-5223.
10. Fais, S. Cannibalism: a way to feed on metastatic tumors. Cancer Lett. 2007, 258, 155-164.
11. Lugini, L.; Lozupone, F.; Matarrese, P.; Funaro, C.; Luciani, F.; Malorni, W.; Rivoltini, L.; Castelli, C.; Tinari, A.; Piris, A.; Parmiani, G.; Fais, S. Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: A key role of ezrin. Lab Invest. 2003, 83, 1555-1567.
12. Lugini, L.; Matarrese, P.; Tinari, A.; Lozupone, F.; Federici, C.; Iessi, E.; Gentile, M.; Luciani, F.; Parmiani, G.; Rivoltini, L.; Malorni, W.; Fais, S. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res. 2006, 66, 3629-2638.
13. Lozupone, F.; Perdicchio, M.; Brambilla, D.; Borghi, M.; Meschini, S.; Barca, S.; Marino, M.L.; Logozzi, M.; Federici, C.; Iessi, E.; De Milito, A.; Fais, S. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep. 2009, 10, 1348-1354.
14. Goss, P.E.; Chamebrs, A.F. Does tumour dormancy offer a therapeutic target? Nat. Rev. Cancer 2010, 10, 871-877.
15. Gatenby, R.A.; Gillies, R.J. A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 2008, 8, 56-61.
16. Huber, V.; De Milito, A.; Harguindey S.; Reshkin, S.J.; Wahl, M.L.; Rauch, C.; Chiesi, A.; Pouysségur, J.; Gatenby, R. A.; Rivoltini, L.; Fais, S. Proton dynamics in cancer. J. Transl. Med. 2010, 8, 57.
17. Fais, S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism J. Intern. Med. 2010, 267, 515-525.
18. Luciani, F.; Spada, M; De Milito, A.; Molinari, A.; Rivoltini, L.; Montinaro, A.; Marra, M.; Lugini, L.; Logozzi, M.; Lozupone, F.; Federici, C.; Iessi, E.; Parmiani, G.; Arancia, G.; Belardelli, F.; Fais, S. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J. Natl. Cancer Inst. 2004, 96, 1702-1713.
19. Abbate, F.; Casini, A.; Owa, T.; Scozzafava, A.; Supuran, C.T. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg. Med. Chem. Lett. 2004, 14, 217-223.
20. Genis, C.; Sippel, K.H.; Case, N.; Cao, W.; Avvaru, B.S.; Tartaglia, L.J.; Govindasamy, L.; Tu, C.; Agbandje-McKenna, M.; Silverman, D.N.; Rosser, C.J.; McKenna, R. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties. Biochemistry 2009, 48, 1322-1331.
21. Teicher, B.A.; Liu, S.D.; Liu, J.T.; Holden, S.A.; Herman, T.S. A. carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res. 1993, 13, 1549-1556.
22. Harguindey, S.; Arranz, J.L.; Wahl, M.L.; Orive, G.; Reshkin, S.J. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res. 2009, 29, 2127-2136.
23. Harguindey, S.; Orive, G.; Pedraz, J.L.; Paradiso, A.; Reshkin, S.J. The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin-one single nature. Biochim. Biophys. Acta 2005, 1756, 1-24.
24. Orive, G.; Reshkin, S.J.; Harguindey, S.; Pedraz, J.L. Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis. Br. J. Cancer 2003, 89, 1395-1399.
25. Arakaki, N.; Nagao, T.; Niki, R.; Toyofuku, A.; Tanaka, H.; Kuramoto, Y.; Emoto, Y.; Shibata, H.; Magota, K.; Higuti, T. Possible role of cell surface H+-ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol. Cancer Res. 2003, 1, 931-939.
26. Kelkel, M.; Jacob C.; Dicato, M.; Diederich, M. Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies. Molecules 2010, 15, 7035-7074.
27. Patel, V.B.; Misra, S.; Patel, B.B.; Majumdar, A.P. Colorectal cancer: Chemopreventive role of curcumin and resveratrol. Nutr. Cancer 2010, 62, 958-967.
28. De Milito, A.; Fais, S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005, 1, 779-786.
29. De Milito, A.; Fais, S. Proton pump inhibitors may reduce tumour resistance. Expert Opin. Pharmacother. 2005, 6, 1049-1054.
30. Axelrod, R.; Axelrod, D.E.; Pienta, K.J. Evolution of cooperation among tumor cells. Proc. Natl. Acad. Sci. USA 2006, 103, 13474-13479.
31. Certo, M.; Moore, D.V.; Nishino, M.; Wei, G.; Korsmeyer, S.J.; Armstrong, SA; Letai, A. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 2006, 9, 351-365.
32. Martin, N.K.; Gaffney, E.A.; Gatenby, R.A.; Maini, P.K. Tumour-stromal interactions in acid-mediated invasion: a mathematical model. J. Theor. Biol. 2010, 267, 461-470.
33. Gatenby, R.A.; Gawlinski, E.T.; Gmitro, A.F.; Kaylor, B.; Gillies, R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006, 66, 5216-5223.